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ABSTRACT  
Chlamydia trachomatis is the leading cause of  bacterial sexually transmitted disease worldwide resulting in 
4-5 million new cases of  Chlamydia annually and an estimated 100 million cases per annum. Infections 
of  the lower female genital tract (FGT) frequently are asymptomatic so they often remain undiagnosed 
or untreated. If  infections are either not resolved, or are left untreated, chlamydia can ascend to the 
upper FGT and infect the fallopian tubes (FTs) causing salpingitis that may lead to functional damage 
of  the FTs and tubal factor infertility (TFI).  
Clinical observations and experimental data have indicated a role for antibodies against C. trachomatis 
proteins such as the 60kDa heat-shock protein 60 (cHSP60) in the immunopathogenesis of  TFI. When 
released from infected cells cHSP60 can induce pro-inflammatory immune responses that may 
functionally impair the FTs leading to fibrosis and luminal occlusion.  
Chlamydial pathogenesis of  irreversible and permanent tubal damage is a consequence of  innate and 
adaptive host immune responses to ongoing or repeated infections. The extracellular matrix (ECM) 
that is regulated by metalloproteinases (MMPs) may also be modified by chlamydial infections of  the 
FGT.  This review will highlight protective and pathogenic immune responses to ongoing and repeated 
chlamydial infections of  the FGT.  It will also present two recent hypotheses to explain mechanisms 
that may contribute to FT damage during a C. trachomatis infection. If  Chlamydia immunopathology can 
be controlled it might yield a method of  inducing fibrosis and thus provide a means of  non-surgical 
permanent contraception for women. 
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1. Chlamydial Immunopathology 
 
Chlamydial infections characteristically are chronic (if left untreated) and recurrent (frequent re-
exposure) with multiple infections resulting in worsened disease states.  In women, each episode of 
pelvic inflammatory disease (PID) roughly doubles the risk of permanent tubal damage, irrespective of 
whether the infection is silent or overt [1]. A retrospective study of 1844 women all laparoscopically-
diagnosed with PID due to C.trachomatis showed that 209 (16%) failed to conceive. Of these, 
confirmed tubal factor infertility (TFI) was established in 141 patients with PID. Importantly, the rate 
of infertility was directly associated with the number and severity of PID infections. Specifically, every 
subsequent episode of PID approximately doubled the rate of TFI i.e. 8% upon one C.trachomatis 
infection, to 19.5% from two exposures resulting in infection and an increase to 40% resulting from 
three or more exposures. [2]. 
It is thought that pro-inflammatory cytokines are probably central to this immunopathology and it has 
been reported that chlamydial cryptic plasmid and caspase activation are required for chlamydial tubal 
inflammatory pathologies [3,4]. The damaging disease sequelae (sterility) are caused by inflammation-
based pathology and histopathologically the following are observed; profuse cellular infiltrates 
consisting of mainly polymorphonuclear neutrophils (PMNs) and lymphocytes and lymphoid follicles 
that contain B cells, macrophages & T cells. This represents an intense and chronic inflammatory 
response and may be followed by local epithelial cell proliferation and scar formation.  The physical 
consequence of scarring may lead to tubal occlusion and infertility. Cell Mediated Immunity (CMI) is 
critical for protection against initial acute infection for resolving chronic/persistent chlamydial 
infections and in the pathway to immunopathology.  The final outcome of disease expression in the 
host depends on many factors including chlamydial antigen, cytokine profile, HLA subtype and host 
genetic factors, infectious load and route of infection. 
 
1.1 Chlamydial Antigens and Immunopathogenesis 
It has been hypothesized that host responses triggered by chlamydial infection contribute both to 
protective immunity and to pathogenesis. Antibodies against the chlamydial major outer membrane 
protein (MOMP) are associated with protective host immune responses, which is consistent with the 
findings that immunization with a native MOMP-induced protection in immunised hosts. In contrast, 
antibodies to the chlamydial 60kDa heat-shock protein 60 (cHSP60) and cHSP10 are associated both 
with protection and with chlamydia-induced pathologies, which may provide a partial explanation for 
the 50-year-old observation that whole chlamydial organism-based vaccines designed for preventing 
trachoma in children actually exacerbated pathologies. It has been reported that a combination of 
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chlamydial antigens CT875 and CT147 was able to distinguish women with acute chlamydial infections 
[5].  The chlamydial antigen cHSP60, (as well as CT376, CT557 and CT443) can discriminate women 
with TFI [5].  Casein-o-lytic protese P (ClpP ) is a proteolytic subunit of the ATP-dependent Clp 
protease complex and plays an important role in the degradation of abnormal proteins. Human 
antibodies against C.trachomatis caseinolytic protease P (ClpP) have also recently been linked to TFI [6]. 
  
In up to 70% of primary infections of the genital tract caused by C. trachomatis, the recruitment of 
immune cells that mediate innate and adaptive immune responses are sufficient to clear bacteria.  
However, inflammatory responses resulting either from recurrent infections or from bacteria accessing 
the upper genital tract are known to contribute to the detrimental scarring and pathologies observed in 
certain infected individuals [7, 8]. Chlamydia immunopathology is associated with both tissue 
destruction and cytokine production and involves both the “Immunological and Cellular” paradigms.  
Pathology following chlamydial infection of susceptible individuals is caused by the host immune 
responses to infection and not the infection itself. The “Immunological Paradigm” of chlamydial 
pathogenesis states the importance of antigen specific adaptive cellular responses to infections and 
encompasses two models. The first is the molecular mimicry model that involves cHSP60 and other 
antigens for which there is high homology between chlamydial protein and a human protein. In this 
model the persistence of chlamydia also leads to continuing antigen exposure thus stimulating specific 
anti-chlamydial adaptive cellular responses. The second model involves direct cytokine inflammation in 
which intracellular infection alone leads to cytokine responses, and these cytokine responses continue 
due to low level chronic immune stimulation. 
 
1.2 The role of “chlamydial stress response” in chlamydial immunopathology 
C.trachomatis enters a viable, non-replicating and non-infectious state known as “chlamydial stress 
response’” (traditionally known as persistence) when exposed, for example, to β-lactam antibiotics 
(including penicillin G) in culture. Triggers of the chlamydial stress response also include nutrient 
depletion, IFN-γ exposure (tryptophan depletion) and infection with Chlamydia-phage [9 and reviewed 
in 10]. It has been reported that commonly prescribed penicillins induced the chlamydial stress 
response for C.trachomatis serovar E in vitro when these antibiotics were used at clinically relevant doses 
[11]. More recently it has been reported that aberrant forms of chlamydial inclusions were observed in 
endocervical epithelial cells from women infected with C.trachomatis [12].  These recent observations in 
vivo augur well to support the notion that the persistent forms of C.trachomatis observed in vitro may 
have direct involvement in vivo in chlamydial pathogenesis of the female reproductive tract. 
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Chlamydiae seem to be able to continue (persist and grow slowly) in a range of cell types including 
macrophages and mucosal epithelial cells. Due to chronic antigen stimulation or overproduction during 
persistent infection, the 60 kDa Heat Shock Protein (CT110) of Chlamydia (cHSP60) [13] is speculated 
to incite immune responses that induce immunopathology and reduced fertility in infected hosts. 
 
1.3 cHSP60, cHSP10,  CT443 and Immunopathogenesis 
When released into the extracellular environment cHSP60 induces a local pro-inflammatory immune 
response in fallopian tube epithelia and results in scar formation and tubal occlusion. It is known that 
cHSP60 is a target for both B-cell and T-cell responses once released from Chlamydia-infected cells and 
the 10kDa heat shock protein of Chlamydia (cHSP10) has been identified as a human T-cell target [14].  
Serum antibodies to cHSP10 have also been associated with the severity of human genital tract disease 
[15] and immune reactivity to cHSP10 has also been significantly associated with tubal infertility 
[reviewed in16]. In comparison with levels in fertile women, higher levels of cHSP60 and cHSP10 
mRNA and proteins have been reported in the cervical epithelial cells of C.trachomatis - infected infertile 
women [17]. TFI is also associated with antibodies against cHSP60 but not against human HSP60 
indicating an infectious rather than autoimmune inflammation [18].  The potential role of chlamydial 
heat shock proteins cHSP60 and cHSP10 in apoptosis of primary cervical epithelial cells was recently 
investigated.  Interleukin (IL)-1 β-convertase, Caspase-3, -8 and -9, were up-regulated upon stimulation 
with cHSP60 and cHSP10. It was also reported that cHSP60 and cHSP10 induced caspase expression, 
proinflammatory cytokine production and apoptosis of primary endocervical epithelial cells; hence it 
has been suggested that both cHSP60 and cHSP10 may play roles in the pathogenesis of infertility in 
women with persistent chlamydial infections [19].  
Recently it has been reported that that reactivity of CT443 (60kDa cysteine-rich outer membrane 
protein) with human sera from patients with TFI [20] and sera from monkeys infected in the Fallopian 
tube with C.trachomatis [21] is associated with upper genital tract pathology identifying this chlamydial 
protein as a marker of disease progression in these hosts.  
Persistent chlamydial infection of host cells effectively blocks apoptosis in these cells.  HeLa cells 
infected with gamma interferon (IFN-γ)-induced persistent C.trachomatis serovar D released High 
Mobility Group Box 1 (HMGB1) which is a pro-inflammatory damage-associated pattern molecule 
(DAMP) that acts as a co-stimulatory cytokine.  It is postulated that the release of HGMB1 by these 
Chlamydia-infected cells may also promote chronic inflammation [22].  
2. An alternative Hypothesis of Pathogenesis: “The Cellular Paradigm”  
The cellular paradigm of pathogenesis maintains that host immune responses are initiated and 
prolonged following chlamydial infections of epithelial cells and is depicted in Figure 1 [8].  
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Inflammation following chlamydial infections is associated with Th1 and Th17 cells (that produce IL-
17). IL-6 and TGF-β induce production of Th17 cells and IL-17 inflammatory responses.  In mice 
chronic pathology was associated with an increased Th17 response during C. muridarum genital tract 
infection [23].  IL-23 is required for Chlamydia-specific Th17 response and for IL-17 production in the 
genital tract [24] and development of oviduct pathology during C.muridarum infections in mice is 
associated with IL-17 signalling [25, 26].  
In sexually-active adolescent females Chlamydia-specific IL-17 responses were low but CD4 IFN-γ 
responses were detected in PBMCs of acutely or previously chlamydia-infected individuals [27]. IL-17 
and IL-22 levels were significantly higher in Chlamydia-infected women than in non-infected women 
and levels of IL-17 and IL-22 were slightly higher in cervical cell than in PBMC supernatants from C. 
trachomatis infected patients [28]. The presence of IL-17 and IL-22 at a site of human C. trachomatis 
infection (cervical cells) indicates that further experiments are needed to determine whether IL-17 and 
IL-22 are involved in protection, in pathogenesis, or are non-specific indicators of inflammation.   
3. Host Genetic Factors 
Not all individuals develop scarring sequelae following chlamydial infections of the genital tract thus 
host factors are likely to influence disease outcomes following chlamydial infections. Genetic variations 
in the expression of IL-10 and IFN-γ genes were associated with the intensity of lymphocyte 
proliferation responses to C.trachomatis antigens in infected women. Susceptibility to disease and 
severity of C.trachomatis-induced tubal damage can be affected by host polymorphisms in TNF, IL-10 
and IFN-γ genes with reports indicating that IL-10 promoter polymorphisms and HLA Class II DQ 
alleles increase TFI risk in chlamydia-infected women. TNF-α 308A allele and the IL-10 1082A allele 
are risk factors for Fallopian tube damage in Chlamydia-infected women [7, 29]. Carrying multiple 
single nucleotide polymorphisms (SNPs) in C. trachomatis host Pattern Recognition Receptor (PRR) 
genes may result in aberrant immune responses and a higher risk of tubal pathology following a C. 
trachomatis infection [30]. It is noteworthy, however, that SNPs for the TLR2 gene have been associated 
with protection against tubal damage following C.trachomatis infections [31]. 
Human TNF-related apoptosis-inducing ligand receptor (TRAIL-R1) is known to regulate 
inflammation and since inflammation is a host response to C.trachomatis infections this receptor was 
recently examined for its effects on chlamydial infections in women.  In a population of 760 women 
(18-55 years old) with (16.7%) and without C. trachomatis infections, the TRAIL-R1+626 homozygous 
mutant GG was found to be significantly associated with C. trachomatis infection. It was also reported 
that depletion of TRAIL-R1 expression in human cervical epithelial cells (HeLa cells) resulted in a 
higher level of the IL-8 mRNA expression and protein secretion during a C. trachomatis infection.  This 
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chemokine is known to be an indicator of the early stages inflammation following infection. It was 
concluded by Al-Kuhlani and colleagues that TRAIL-R1 negatively regulates pro-inflammatory 
responses and therefore that this receptor may contribute to modulating the long-term chlamydial 
disease sequelae in humans [32]. 
4. C. trachomatis infections and the Fallopian tube 
Ciliated epithelial cells and macrophages are the primary targets of Chlamydia trachomatis infections of 
the Fallopian tube [33, 34].  C.trachomatis infection directly induces loss of microvilli and cilia from 
epithelial cells of human Fallopian tube organ cultures [35]. Chlamydial infection of the Fallopian tube 
causes substantial disturbance of epithelial tissue homestasis by the paracrine Wnt signalling pathway 
and it has been observed that Chlamydia-induced damage spreads beyond the infected ciliated cells [36]. 
Indeed,  in the absence of leukocyte infiltration, chlamydial infections induce epithelial IL-1β and IL-1 
receptor Type 1 synthesis that initiate destruction of Fallopian tubes in an ex vivo model [37].  Following 
chlamydial infections of epithelial cells, CD4 and CD8 T- lymphocytes infiltrate and release 
chemokines and cytokines into the cervical secretions and Fallopian tubes causing sustained 
inflammation.  Tumor necrosis factor (TNF)-α is increased in response to chlamydial infections of 
Fallopian tubes [38] along with many other pro-inflammatory cytokines and chemokines including 
interleukin (IL)-6 and IL-8 [35].  It is proposed that inflammation is a major cause of chronic Fallopian 
tube tissue damage in seen in C. trachomatis-infected infertile women [39].  The fact that IL-1 destroys 
ciliated cells means, however, that leukocyte infiltration is not actually needed to initiate destruction of 
Fallopian tube tissue. Therefore, it is also possible that the induction of this interleukin may cause 
scarring of the Fallopian tubes and subsequently TFI; however, the mechanism by which this damage 
occurs remains unresolved. 
5. What is the mechanism of Chlamydia-induced tubal damage? 
Chlamydia infection can target host proteins involved in inflammation and fibrosis e.g. Caspase-1, 
Matrix metalloproteinase (MMP)-9. The MMPs are endopeptidases that are required for normal tissue 
homeostasis. They play roles in the pathogenesis of a range of inflammatory-fibrotic diseases, 
disrupting the basement membrane and aiding the recruitment of inflammatory cells [40]. Neutrophils 
can produce MMPs [41] and the Th1 cytokine IFN-ϒ is also an inducer of MMPs [42]. Chlamydial 
infection of epithelial cell monolayers in vitro results in the differential expression of extracellular matrix 
(ECM) components such as mucins and MMPs [43].  MMPs are linked to oviduct fibrosis and 
Chlamydia-induced scarring (MMP-2) [44] and have been identified in Chlamydia- infected Fallopian tube 
organ cultures (MMP-9) [45].  
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It is apparent from the results of both ex vivo and in vivo studies that C.trachomatis infections of the 
genital tract mucosa can cause severe damage to the Fallopian tubes. What remains to be resolved 
is/are the mechanism(s) involved in producing these detrimental effects that lead to blockage of the 
Fallopian tubes and TFI. The salient points of mechanisms proposed to explain chlamydial-induced 
tubal damage will be presented for two of three current hypotheses; (1) Activins, iNOS and Nitric 
Oxide (NO) and (2) Multiple Positive Feedback Loops. An additional hypothesis for chlamydia 
infection-induced infertility involves the Caspase-DICER-miRNA pathway [46]; however this latter 
hypothesis will not be discussed in the current review. 
5.1 Activins, iNOS and Chlamydia 
Activins are responsive to TLR2 activation and are secreted by tubal epithelial cells [47]. Increased 
expression levels of activin βA (a member of the TGF-β family) were reported within the Fallopian 
tubes from 14 women with ectopic pregnancy (EP) who were also serologically positive for C. 
trachomatis infection [48]. In Fallopian tube explants it was reported that TLR2 was activated in the 
tubal epithelium following treatment with C.trachomatis [49].  Since activins respond to TLR-2 activation 
and TLR2 signalling is induced in response to C. trachomatis infection (both in vivo and ex-vivo) it has 
been proposed that TLR-2 activation may lead to increased activin A expression by chlamydia- infected 
tubal epithelial cells [50]. Increased expression of activin A by tubal cells potentially may be a 
significant cause of tubal fibrosis in C.trachomatis-infected women, since the prolonged /increased 
expression of activins is noted in other inflammatory and fibrotic human diseases such as rheumatoid 
arthritis and inflammatory bowel disease [51]. 
Inducible nitric oxide synthase (iNOS) that generates nitric oxide (NO) is also produced by the human 
Fallopian tube in response to C.trachomatis genital infection.   Increased expression levels of iNOS were 
also recorded within the Fallopian tube from women with EP who had detectable chlamydial 
antibodies to the C.trachomatis major outer membrane protein (MOMP) and also in patients that only 
had antibodies to cHSP-60 [48].  A model proffered to explain chlamydia-induced tubal EP suggests 
that the cytokine/chemokine-induced iNOS-derived production of NO may contribute to infection-
induced immune-pathology by promoting scar formation and tissue remodelling of the Fallopian tube 
that ultimately may lead to permanent tubal damage;  this model is reproduced in Figure 2 [52]. 
5.2 Hypothesis for Chlamydia-induced fibrotic scarring: Multiple positive feedback loops 
A second hypothesis to explain Chlamydia-induced fibrotic scarring was recently developed when 
cultures that were established with low multiplicity of bacterial infection were profiled using deep 
sequencing of cDNA libraries. In this study C.trachomatis serovar E-infected cancerous epithelial cell 
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monolayers were simultaneously profiled for the transcription factors of both Chlamydia and the 
eukaryotic cells they infected [43]. From this study it was seen that host derived tissue damaging factors 
were released following infection of epithelial cells as soon as 1 hour post-infection. There was 
evidence of attempted immune dampening during this time-course as well as early transcription of host 
factors that have been linked to scar-formation and fibrosis in other conditions. These authors thus 
propose that the initial infection of host cells could potentially drive responses that ultimately cause the 
deleterious effect of scarring. Briefly the salient features of the model proposed (See Figure 3) involve 
the following steps [43]: 
1. Ongoing inflammatory stimulation (infection or re-infection ) from chlamydial elementary 
bodies 
2. Recruitment and activation of immune cells that participate in the fibrotic response (collagen-
depositing fibroblasts) and secrete MMPs. Host factors that are associated with scar-formation 
and other fibrotic conditions were evidenced 1 hour post infection of host cells with Chlamydia. 
3. MMP-2 and MM-P9 activity induce Tenascin-C (an ECM glycoprotein) expression  
4. Scarring exacerbated through positive feedback loop of MMP/Tenascin-C  
Finally, it has recently been opined that the tendency of C. trachomatis (and other pathogens) to cause 
Sexually Transmitted Infections (STIs) likely reflects the existence of targeted patho-mechanisms used 
by these pathogens to cause infertility. The authors of this hypothesis note that sexually transmitted 
infections (STIs) cause little mortality and morbidity in their infected hosts.  The authors present 
evidence that infertility promotes STI transmission and they state that this provides a “convincing 
case” for an evolutionary adaptation of the pathogen that allows the organism to benefit from reducing 
fertility in the host; they have termed this an “adaptive sterilization hypothesis”[53]. 
6. Conclusion 
In conclusion this review has highlighted data to support the notion that Chlamydia- induced 
inflammation and fibrotic scarring of the Fallopian tubes is likely to be preferentially associated with: 
1. Host reactivity with CT110 (cHSP60) , CT111 (cHSP10) and CT443 (60kD  CrP (cysteine-rich 
outer membrane protein)  
2. Early increased and persistent expression of host genes associated with fibrosis 
3. Increased expression of tubal activins and iNOS within the tube involved in the immune 
response to Chlamydia 
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It is possible that these proposed mechanisms of Chlamydia-induced scarring could be used to inform 
strategies for therapeutic occlusion of the Fallopian tubes and thus perhaps for a means of non-surgical 
permanent contraception for women. Of concern however is the risk that such an antigen-based 
approach may induce undesirable systemic effects. Thus, for Chlamydia-induced infertility to provide a 
promising novel permanent contraceptive for women there are research questions that need to be 
addressed via proof-of-principle studies in animal models including:  
1. Which chlamydial antigens would be best to use for inducing immunopathology to cause tubal 
blockage?  
2. Can we control the immunopathological consequences of this antigen-based approach? 
3. How “permanent” is the tubal occlusion? 
4. Is a primary “vaccination” enough to induce tubal damage? 
5. Will local activation of innate immune responses alone in reproductive tissues result in tubal 
occlusion? 
6. Do oral contraceptives enhance pathology? 
7. Are repeated episodes of salpingitis required for tubal scarring? 
8. What is the role of ongoing antigen stimulation? 
9. Do antigens need to be delivered continually to induce damage? 
10. What biomarkers of pathology/scarring / EP should be measured? 
Answers to these questions would augur well for the development of a low-cost nonsurgical approach 
for permanent female contraception.   
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FIGURE LEGENDS 
Figure 1: The cellular pathogenesis model of Chlamydia infection 
Initial infection of non-immune cells with C.trachomatis results in the release of large amounts of pro-
inflammatory chemokines.  This pro-inflammatory response continues even under persistence 
conditions where growth factors continue to be produced which promote cellular proliferation, tissue 
remodelling and eventual scarring.  Re-infection and/or persistent infection maintains the antigen non-
specific process as well as inciting an additional level of specific immune responses (which are 
secondary). Reprinted from [8] with permission from Elsevier.  
 
Figure 2: A simplified view of inflammation-induced iNOS-derived NO production that 
accounts for tubal Ectopic Pregnancy (EP) in humans infected with C. trachomatis [51]. 
Fallopian tubes infected with C. trachomatis (a) results in the synthesis of cytokines and chemokines in 
epithelial cells (epi) and macrophages (b). As secretion, in turn, autocrine and paracrine up-regulation 
of iNOS expression (b, c) induces an inappropriate NO production (d). The excessive iNOS-derived 
NO production promotes tissue remodelling and scarring, leading to tubal cell damage and destruction 
that may contribute to the development of infection-induced tubal EP. Pharmacological tools to 
modulate this process might be of therapeutic relevance. sm cell, smooth muscle cell. Reprinted from 
[52] with permission from Oxford University Press (OUP). 
 
Figure 3:  A proposed model of chlamydial-induced fibrosis and chronic scarring through the 
induction of multiple positive feedback loops. 
Infection of epithelial cells by Chlamydia leads to production of proinflammatory cytokines and 
chemokines that lead to recruitment and activation of immune cells. Recruited immune cells and 
infected epithelial cells secrete pro-fibrotic matrix metalloproteases (MMPs) that act upon the 
extracellular matrix (ECM), including collagens. The breakdown products of these proteases are also 
pro-inflammatory. Infected epithelial cells express the pro-fibrotic molecules TGF-β, Gremlin1 and 
Tenascin-C; expression of each amplifies the other, creating a series of nested positive feedback loops 
that increase the deposition of collagens and other ECM components, which in turn further induce 
immune cell recruitment and activation. Note:  Gremlin1 (GREM-1) - protein that converts epithelial 
cells to fibrotic myofibroblasts; TGF-β induces GREM1 production. Reprinted from [43] Open-Access 
License and no permission required.  
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